Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

allogeneic GM-CSF-based myeloma cell vaccine

An allogeneic tumor cell vaccine containing myeloma cancer cells transfected with the granulocyte macrophage-colony-stimulating factor (GM-CSF) gene with potential antineoplastic activity. Upon vaccination, allogeneic GM-CSF-based myeloma cellular vaccine secretes GM-CSF, which may potentiate a tumor-specific cytotoxic T-lymphocyte (CTL) response against myeloma cancer cell-associated antigens.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	allogeneic granulocyte macrophage colony-stimulating factor-based myeloma cellular vaccine allogeneic granulocyte macrophage colony-stimulating factor-transfected myeloma cell vaccine

allogeneic GM-CSF-based myeloma cell vaccine

Search NCI's Drug Dictionary